“…Because D-galactose is primarily processed in the liver, a high level of D-galactose in the body might hurt the liver. Treatment with Dgalactose has been shown to cause oxidative stress in the liver by increasing Nitric oxide, malondialdehyde, and 8-hydroxy-2-deoxyguanosine while decreasing Catalase, glutathione peroxidase, superoxide dismutase, nitric oxide synthase, reduced glutathione, and total antioxidant capacity in liver tissues (Chen et al, 2011(Chen et al, , 2018Feng et al, 2016;Ji et al, 2017;Kong et al, 2018;Lei et al, 2016;Li et al, 2005;Liu et al, 2018;Mo et al, 2017;Mohammadi et al, 2018;Noureen et al, 2019;Shahroudi et al, 2017;Xu et al, 2016;Yang et al, 2019;Zhuang et al, 2017). The intracellular (p38 mitogen-activated protein kinasenuclear factor erythroid 2-heme oxygenase-1) ( p38 MAPK-NRF2-HO-1) signaling pathway in the liver has been shown to activate by D-galactose therapy (Gao et al, 2018;Lin et al, 2018).…”